Home » Newsletters » BioWorld Asia

BioWorld Asia

Sep. 6, 2000

View Archived Issues

Neurotech, NsGene Collaborate On Encapsulated Cell Technology

Serotonin Receptor Influences Heart Development, Study Shows

Aventis Team Forms Discovery Company Argenta, Raises #7M

Cantab Getting #5.7M, Rights To Herpes Vaccine From Glaxo

BresaGen Buying CytoGenesis, Merging Cell Therapy Programs

Other News To Note

Cerep, Solvay Enter Contract For Drug Discovery Services

Serendipity Leads Canadians To Inhibitor Of Colon Cancer

European Commission Wants Larger Role In Cloning Debate

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026